Head-to-head dispatch
Embody vs NuuVim
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.
Marked down on: The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
Desk Score
NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.
Marked down on: There is no month-to-month plan: every rate is billed as one three-month payment
Embody takes this head-to-head with the higher Desk Score, 83/100 (B) against 64/100 (C) for NuuVim. NuuVim still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Embody
83/100
B
NuuVim
64/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Embody | NuuVim |
|---|---|---|
| Semaglutide | $79/mo (all doses, promotional rate, compounded) | $79/mo (all doses, 3-mo plan, new patients only, compounded) |
| Tirzepatide | $129/mo (all doses, promotional rate, compounded) | $133/mo (all doses, 3-mo plan, new patients only, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name | Compounded only | Yes |
| Oral option | Yes | Yes |
| Best for | Readers who want low flat-rate compounded GLP-1 pricing at every dose. | Readers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing. |
| Desk Score | 83/100B | 64/100C |
The verdict
Desk pick — EmbodyEmbody takes this head-to-head with the higher Desk Score, 83/100 (B) against 64/100 (C) for NuuVim. NuuVim still holds its ground where its strengths line up with yours.
Choose Embody if…
Readers who want low flat-rate compounded GLP-1 pricing at every dose.
$79/mo (all doses, promotional rate, compounded) sema · $129/mo (all doses, promotional rate, compounded) tirz · All 50 states
Choose NuuVim if…
Readers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.
$79/mo (all doses, 3-mo plan, new patients only, compounded) sema · $133/mo (all doses, 3-mo plan, new patients only, compounded) tirz · Coverage not published
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Embody · NuuVim.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Embody vs CoreAge Rx
- NuuVim vs Vaylen
- Embody vs Strut Health
- NuuVim vs Ondra Health
- Embody vs Invigor Medical
- NuuVim vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.